Jim Cramer Blog

Here are 7 stocks for traders for Thursday from TradingMarkets.com:
Gymboree (NasdaqGS:GYMB) beat earnings on Wednesday after the close, announcing $0.67 EPS over an estimated $0.63 EPS. GYMB's PowerRating is 4.

Hot Topic (NasdaqGS:HOTT ) missed earning on Wednesday afternoon; analysts were looking for -$0.02 EPS, but HOTT reported -$0.03 EPS. HOTT's PowerRating is 4.
AnnTaylor (NYSE:ANN) reports earnings on Thursday before the stock market opens; watch for $0.45 EPS. ANN's PowerRating is 4.
Barnes & Noble (NYSE:BKS) is expected to announce $0.01 EPS before the bell on Thursday. BKS's PowerRating is 5.
Analysts are watching for Jabil Circuit (NYSE:JBL) to report $0.38 EPS in quarterly earnings on Thursday morning. JBL's PowerRating is 4.
When Toll Brothers (NYSE:TOL) reports earnings on Thursday morning before the market opens, look for $0.14 EPS. TOL's PowerRating is 4.
Mylan Labs (NYSE:MYL) should report $0.55 EPS tomorrow morning. MYL's PowerRating is 4.
PowerRatings are courtesy of PowerRatings.net

Labels: ANN, BKS, GYMB, Hot Stocks, HOTT, JBL, MYL, TOL

Symbol
Name
Last Trade
Change
Volume
Related Info
CTTY
CATUITY INC
1.67 4:00PM ET
0.58 (25.78%)
233,599

WYY
WIDEPOINT CORP
0.93 4:02PM ET
0.21 (18.42%)
1,232,900
KRSL
KREISLER MFG CO
22.67 4:00PM ET
4.34 (16.07%)
218,297
QADI
QAD INC
7.90 4:00PM ET
1.47 (15.69%)
265,459

ANV
ALLIED NEVADA GOLD
4.16 3:59PM ET
0.73 (14.93%)
340,200

SORC
SOURCE INTERLINK
5.79 4:00PM ET
1.01 (14.85%)
1,777,066

HINTW
HILL INTERNATIONL WT
2.29 3:58PM ET
0.35 (13.26%)
72,269

GRZ
GOLD RESERVE INC
6.00 4:00PM ET
0.89 (12.92%)
2,204,800

SFP
SALTON INC
1.70 4:03PM ET
0.25 (12.82%)
206,400

VGZ
VISTA GOLD NEW
6.52 4:02PM ET
0.90 (12.13%)
592,590
ICOPW
ICOP DIGITAL WARRANT
2.62 3:59PM ET
0.36 (12.08%)
105,706

MYL
MYLAN LABS INC
19.70 4:00PM ET
2.70 (12.05%)
29,860,562

TINY
HARRIS & HARRIS
12.05 4:00PM ET
1.61 (11.79%)
1,035,132

XRA
EXETER RESOURCE CORP
2.09 3:57PM ET
0.27 (11.44%)
104,000

CFHI
COAST FINL HLDGS INC
4.40 3:59PM ET
0.53 (10.75%)
71,422

TNH
TERRA NITR CO COM UT
85.66 4:01PM ET
10.09 (10.54%)
1,589,707
LPHI
LIFE PARTNERS HLDGS
16.96 3:59PM ET
1.90 (10.07%)
130,903
AZK
AURIZON MINES LTD
3.14 4:01PM ET
0.34 (9.77%)
1,034,300

OPMR
OPTIMAL GROUP
7.96 4:00PM ET
0.85 (9.65%)
818,574

Labels: ANV, AZK, CFHI, CTTY, GRZ, HINTW, ICOPW, KRSL, LPHI, MYL, OPMR, QADI, SFP, SORC, TINY, TNH, VGZ, WYY, XRA

Stocks traded aimlessly again today as investors waited for the start of earnings season, which traditionally kicks off with an announcement from aluminum producer Alcoa (NYSE: AA - News). The major market averages all managed to post modest gains. Oil prices were also higher, as was the 10-year Treasury note, which saw its yield drop to 4.72%.
Housing was once again in the spotlight as homebuilder D.R Horton (NYSE: DHI - News) announced that is Q2 sales orders fell 37% overall, paced by even steeper declines in the formerly booming California and the Southwest markets. The company's net orders totaled 9,983 homes, down from 15,771 homes last year. Horton's Q2 ended March 31st. The stock closed -1.5% lower.
In corporate news, Swedish telecom equipment maker LM Ericsson (Nasdaq: ERIC - News) signed a deal to manage a portion of the European network of Vodafone (NYSE: VOD - News). Ericsson's shares added 3.6% on the news. Citigroup (NYSE: C - News) was up 1.6% as investors waited for the results of its long-anticipated cost review. Generic drugmaker Mylan Laboratories (NYSE: MYL - News) rose 2.8% after it raised its 2007 profit forecast to a range of $1.60 to $1.63 a share, up from its previous guidance of $1.50 to $1.55 per share. Mylan cited strength in its generics business, including new product launches, for its upbeat forecast.
The flip side of the drug business was exemplified by biopharmaceutical company Adolor (Nasdaq: ADLR - News), which saw its shares plunge -58.7% after it announced that it stopped a study of a new drug to treat opioid-induced (OIC) constipation over safety concerns. The drug, Entereg, was being developed in association with British drugmaker GlaxoSmithKline (NYSE: GSK - News). Several analysts swiftly issued downgrades for Adolor, while Brean Murray Carret reiterated its "sell" recommendation. Progenics Pharmaceuticals (Nasdaq: PGNX - News), which submitted its own OIC compound for FDA approval last Friday along with partner Wyeth (NYSE: WYE - News), added 1.5% today.
Shares of ImClone Systems (Nasdaq: IMCL - News) also slid -6.4% on poor trial results. The company said a late-stage trial of its cancer drug Erbitux failed to extend survival in patients with pancreatic cancer. Erbitux is already approved for treatment of colorectal cancer, and head and neck cancer.
In M&A news, Biosite (Nasdaq: BSTE - News) said it will enter merger talks with Inverness Medical Innovations (NYSE: IMA - News), which last week offered $90 a share for the maker of medical diagnostic tests. IMA's bid topped an earlier offer from Beckman Coulter (NYSE: BEC - News) of $85. All three companies are in the business of making medical test products.

Labels: AA, ADLR, BEC, BSTE, C, DHI, ERIC, GSK, IMA, IMCL, MYL, PGNX, VOD, WYE

Stocks were narrowly mixed Tuesday as investors refrained from major moves ahead of first-quarter earnings reports that begin with Alcoa Inc.'s results after the closing bell.
The aluminum producer is expected to post a profit of 75 cents per share. Wall Street looks to results from the component of the Dow Jones industrial average to not only gauge the pace of earnings for the quarter but as a proxy for the health of the overall economy.
Stocks also showed little overall movement Monday as investors awaited news of how companies fared during the first quarter, and also their expectations for the coming quarters. In the fourth quarter, Standard & Poor's 500 companies snapped an 18-quarter streak of double-digit profit gains, and Wall Street expects profit growth to remain in the single digits for the first three months of the year. In midday trading, the Dow fell 13.17, or 0.10 percent, to 12,555.97.
Broader stock indicators were slightly higher. The S&P 500 edged up 0.44, or 0.03 percent, to 1,445.05, and the Nasdaq composite index rose 2.75, or 0.11 percent, to 2,471.93.
Bonds continued to recover, with the yield on the benchmark 10-year Treasury note falling to 4.71 percent from 4.75 percent late Monday. Gold prices rose, while the dollar was mixed against other major currencies after the United States filed two complaints against China at the World Trade Organization over copyright policy. The currency is at a two-year low against the euro.
Oil prices rose after selling off Monday following doubts about Iran's comments about its uranium-enrichment achievements. A barrel of light, sweet crude for delivery on the New York Mercantile Exchange rose 36 cents to $61.87. Investors were also awaiting minutes from the Fed's most recent meeting at which it left short-term interest rates unchanged for the sixth straight time. In corporate news, Dow Chemical Co. fell $1.23, or 2.6 percent, to $45.40 after the chemical and plastics maker said it has had no discussions about a leveraged buyout. Citigroup Inc. rose 52 cents to $52.10 ahead of a major restructuring announcement, where some 26,000 workers will be reassigned or their jobs eliminated, according to a report in The New York Times. D.R. Horton Inc., the nation's largest homebuilder by deliveries, said its second-quarter sales orders fell 37 percent, led by even steeper declines in California and the Southwest. Shares fell 33 cents to $21.71.
Adolor Corp. fell $5, or 57.3 percent, to $3.72 after the biopharmaceutical company stopped clinical studies and withdrew an application for a constipation-relief drug, leading to a series of downgrades.
Shares of drug maker Mylan Laboratories Inc. jumped 65 cents, or 3.1 percent, to $21.85 after the company raised its profit forecast, citing continued strength in its generics business and new product sales.
Declining issues outnumbered advancers by about 9 to 5 on the New York Stock Exchange, where volume came to 551.4 million shares.
The Russell 2000 index of smaller companies rose 2.61, or 0.32 percent, to 814.25.
Overseas, Japan's Nikkei stock average closed down 0.45 percent. In afternoon trading, Britain's FTSE 100 rose 0.32 percent, Germany's DAX index rose 0.94 percent, and France's CAC-40 rose 0.43 percent.
Source: AP

Labels: AA, ADLR, C, DHI, DOW, MYL